Pain Clinical Trial
Official title:
Long Term Use of a High Energy Pulsed Heating Device in the Management of Chronic Pain
The purpose of this study is to evaluate the Soovu Labs pain Relief System in a group of users that represent people most likely to purchase and use the units. This study is called an In Home Users Trial (IHUT). The device is called Soovu and was determined by the FDA to be Class II 510(k) except (C190061 November 2019). Relevant endpoints include ease of use, pain relief, quality of life, and long-term effectiveness.
Soovu device description:
From the FDA document (C190061) "The system is indicated to provide topical heating for the
purpose of elevating tissue temperature for the temporary relief of minor muscle and joint
pain and stiffness; the temporary relief of joint pain associated with arthritis; the
temporary relief of muscle spasms, minor sprains and strains, and minor muscular back pain;
the temporary relief of menstrual discomfort; the relaxation of muscles; and the temporary
increase of local circulation where applied." The devices are constructed following
documented ANSI/AAMI ES60601-1, ANSI/AAMI HA60601-1-11, IEC 60601-1-2, IEC 60529, ISO
10993-5, and 10993-10 safety standards.
The device consists of two separate heating units pods that are attached to the body via a
ring coated with medical grade adhesive. The units are easily removed from the body. The
units are controlled by a phone app that the user downloads to his or her phone and pairs
with the units via Bluetooth. The app contains instructional material on how to use the
device and general information related to pain management. The user may start and end heat
cycles via the app, may adjust the temperature of the unit, and select from one of three
heating profiles. The maximum temperature of the unit is 113° F well within accepted safety
limits. The three heating algorithms are:
1. Waves of heat up 113F that occur about 2 times per minute for up to 30 minutes
2. Waves of heat up 113F that occur about 4 times per minute for up to 30 minutes
3. Waves of heat up 113 F that occur about 2-3 times per minute for up to 30 minutes. These
waves of heat are synchronized with instructions in the app that guide users through
relaxed breathing exercises sometimes called box breathing. This option lasts up to 30
minutes.
The user can freely select any of the options, can end the session before the 30 minute time
out, and can reduce the maximum temperature of the heat wave from 113° F all via the app.
Objective(s) To assess the consumer experience of Soovu Labs wearable thermal pulsed-heat
device with Blue-tooth connected app among patients with recurring lower back. Assessment
will include a) whether the device is perceived to work in managing their pain, b) if the
device is comfortable to wear and use, c) if the app is easy to use, and d) if patients would
purchase the product and replacement adhesive.
Design Single arm. home-use study
Treatment Participants will be provided with a Soovu Labs device. Back pain sufferers will
apply the product to their pain site as needed following label instructions during an
approximate 60 day usage period. Participants will download the app to their personal mobile
phone.
Number of Patients A total of 40 participants will be recruited for the study.
Rationale Pain is an unpleasant sensory and emotional experience that is associated with
actual or potential tissue damage or is described associated with such damage. It causes
significant disability and dramatically decreases the patients' quality of life especially if
it lasts for a long time and becomes chronic. Many key opinion leaders and experts in
orthopedics and rheumatology accept that the pain is considered chronic if it lasts more than
six months. Chronic neck, back, and shoulder pain are among the most common and disabling
conditions accompanying different musculoskeletal disorders. As many other chronic painful
conditions, they are very disabling and lead to considerable stress on healthcare systems.
Several treatment modalities and their combinations have been proposed with different success
rates, including exercises, physical therapy, oral medication, injections and even surgery.
However, many products have low satisfaction rates given poor design, poor aesthetics, and
limited effectiveness.
The present study suggests a new therapeutic option (pulsed heat) for patients with recurring
lower back or cervical pain. The new wearable device delivers pulsed heat that automatically
raises and lowers the heat intensity over wear time may provide a better patient experience.
This study will assess opinions of likely users about the device.
Study Procedures The IHUT study will be run by Soovu Labs Inc. Seattle, WA.
Subjects may be recruited via an internal database of those who have participated in previous
studies and focus groups as well as new recruits. Subjects will be given the device for home
use for up to 60 days. Prior to entering the study all subjects will be screened for
inclusion/exclusion criteria (Attachment 1). If subjects are eligible and wish to enter the
study, they will complete an intake form (Attachment 2).
Subjects will be mailed the devices, adhesive rings (three different types), charger and
instructional materials including Owner's Manual with appropriate indications, warnings and
cautions, and Quick Start Guide to unbox at home. The attachment rings contain adhesives that
are commercially available, are biocompatible, and approved for human use. Questions related
to the unboxing are listed in attachment 3.
Once entered into the study users will be free to use the Soovu device as needed, with a
recommendation to use daily. The phone app that controls the device automatically tracks the
use of the device. Specifically, location of pain, which treatment profile (1-3) the subject
used, relief post use, the time and number of uses per day, duration of each treatment, and
whether the user viewed any of the supportive instructions contained on the app.
Subjects will periodically be contacted via telephone or internet and asked a set of
questions and opinions . At the conclusion of the study subjects will be contacted via
telephone or internet and asked a set of exit questions as well as to return the study
device.
In addition, a social media site with participation limited to study participants will be
made available for participants to share comments amongst themselves, and for the company to
provide clarifications on product usage as needed.
Criteria for Evaluation of Safety Any adverse event related or unrelated to the tested
products will be documented and reported as required (occurrence date, site, outcome and
assessment of causality and severity etc.) following approved operating procedures. All
adverse events will be recorded in the final study report. Adverse event instructions will be
included in the participant's Informed Consent Statement and in the study materials.
Statistical Methods Data will be analyzed using analysis of variance with pain site, past
treatments, and gender as discrete factors, and age as a covariate. Purchase interested will
be assessed using frequency analysis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05559255 -
Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI
|
N/A | |
Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
Terminated |
NCT04356352 -
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
|
Phase 2/Phase 3 | |
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04466111 -
Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
|
||
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05868122 -
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
|
Phase 3 | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Enrolling by invitation |
NCT06087432 -
Is PNF Application Effective on Temporomandibular Dysfunction
|
N/A | |
Completed |
NCT05508594 -
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
|
Phase 2/Phase 3 | |
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Completed |
NCT03678168 -
A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries
|
N/A | |
Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT02913027 -
Can We Improve the Comfort of Pelvic Exams?
|
N/A | |
Terminated |
NCT02181387 -
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
|
Phase 4 | |
Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
Active, not recruiting |
NCT03613155 -
Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care
|